Last updated: March 18, 2024
Sponsor: Menning Labs
Overall Status: Completed
Phase
N/A
Condition
Acne
Inflammatory Comedones
Rash
Treatment
EQ Moisturizer
EQ Exfoliating Cleanser
EQ Gel
Clinical Study ID
NCT06122467
20365
Ages 18-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Be aged between 18-45.
- Anyone who has acne prone skin and a history of recurring acne.
- Has visible acne at enrollment.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- Have a digital camera or smartphone to take photos of the face.
Exclusion
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants fromadhering to the protocol, including oncological and psychiatric disorders.
- Anyone currently using a prescription skin product.
- Anyone who is unwilling to stop using the current acne supplements they are taking.
- Anyone with known severe allergic reactions.
- Any women who are pregnant, breastfeeding or attempting to become pregnant.
- Anyone unwilling to follow the study protocol.
- Anyone who identifies as having sensitive skin.
Study Design
Total Participants: 36
Treatment Group(s): 3
Primary Treatment: EQ Moisturizer
Phase:
Study Start date:
October 02, 2023
Estimated Completion Date:
December 31, 2023
Connect with a study center
Citruslabs
Santa Monica, California 90404
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.